Indicated for: dyslipidemia
Route of administration: oral
Substance: ciprofibrate (fibrate lipid-lowering agent)
ATC: C10AB08 (Cardiovascular system | Lipid modifying agents, plain | Fibrates)
Ciprofibrate is a lipid-lowering medication used for the treatment of dyslipidemias, particularly hypertriglyceridemia and hypercholesterolemia. It works by reducing triglyceride and LDL cholesterol levels and increasing HDL cholesterol levels.
The medication is taken orally, as directed by a doctor, usually once daily. It is important for patients to follow the treatment regimen and adopt a healthy lifestyle, including a balanced diet and regular exercise.
Patients should be aware of potential side effects, such as gastrointestinal disturbances, muscle pain, or allergic reactions. It is important to inform the doctor of any unusual symptoms.
Common side effects include gastrointestinal disturbances, muscle pain, and fatigue. In rare cases, severe reactions such as rhabdomyolysis or liver dysfunction may occur. Patients should be informed of these risks before starting treatment.